BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen S, Zhu JY, Zang X, Zhai YZ. The Emerging Role of Ferroptosis in Liver Diseases. Front Cell Dev Biol 2021;9:801365. [PMID: 34970553 DOI: 10.3389/fcell.2021.801365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kouroumalis E, Tsomidis I, Voumvouraki A. Iron as a therapeutic target in chronic liver disease. World J Gastroenterol 2023; 29(4): 616-655 [DOI: 10.3748/wjg.v29.i4.616] [Reference Citation Analysis]
2 Casini A, Leone S, Vaccaro R, Vivacqua G, Ceci L, Pannarale L, Franchitto A, Onori P, Gaudio E, Mancinelli R. The Emerging Role of Ferroptosis in Liver Cancers. Life (Basel) 2022;12. [PMID: 36556493 DOI: 10.3390/life12122128] [Reference Citation Analysis]
3 Liu J, Waugh MG. The regulation and functions of ACSL3 and ACSL4 in the liver and hepatocellular carcinoma. Liver Cancer International 2022. [DOI: 10.1002/lci2.68] [Reference Citation Analysis]
4 You H, Wang L, Bu F, Meng H, Huang C, Fang G, Li J. Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases. Cells 2022;11:3301. [DOI: 10.3390/cells11203301] [Reference Citation Analysis]
5 Oh SJ, Ikeda M, Ide T, Hur KY, Lee MS. Mitochondrial event as an ultimate step in ferroptosis. Cell Death Discov 2022;8:414. [PMID: 36209144 DOI: 10.1038/s41420-022-01199-8] [Reference Citation Analysis]
6 Ali N, Ferrao K, Mehta KJ. Liver Iron Loading in Alcohol-Associated Liver Disease. The American Journal of Pathology 2022. [DOI: 10.1016/j.ajpath.2022.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Deng H, Zhang J, Zheng Y, Li J, Xiao Q, Wei F, Han W, Xu X, Zhang Y. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.878648] [Reference Citation Analysis]
8 Yamada N, Karasawa T, Komada T, Matsumura T, Baatarjav C, Ito J, Nakagawa K, Yamamuro D, Ishibashi S, Miura K, Sata N, Takahashi M. DHCR7 as a novel regulator of ferroptosis in hepatocytes.. [DOI: 10.1101/2022.06.15.496212] [Reference Citation Analysis]
9 Peng B, Peng J, Kang F, Zhang W, Peng E, He Q. Ferroptosis-Related Gene MT1G as a Novel Biomarker Correlated With Prognosis and Immune Infiltration in Colorectal Cancer. Front Cell Dev Biol 2022;10:881447. [DOI: 10.3389/fcell.2022.881447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Liu H, Zhao L, Wang M, Yang K, Jin Z, Zhao C, Shi G. FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells. Front Oncol 2022;12:852095. [PMID: 35392237 DOI: 10.3389/fonc.2022.852095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Bekric D, Ocker M, Mayr C, Stintzing S, Ritter M, Kiesslich T, Neureiter D. Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. Cancers (Basel) 2022;14:1826. [PMID: 35406596 DOI: 10.3390/cancers14071826] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
12 Huang C, Zhan L. Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer. Front Pharmacol 2022;13:851540. [DOI: 10.3389/fphar.2022.851540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kusnick J, Bruneau A, Tacke F, Hammerich L. Ferroptosis in Cancer Immunotherapy—Implications for Hepatocellular Carcinoma. Immuno 2022;2:185-217. [DOI: 10.3390/immuno2010014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]